NCT00074308 · Interventional trial
Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers
Overall registry status Completed
Phase 1 · Phase 2
Conditions Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma, Unspecified Adult Solid Tumor, Protocol Specific
Delaware Valley sites
- Abramson Cancer Center of The University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory